Under this partnership, Grann will lead proof-of-concept and preclinical animal studies targeting GABAAR variants, applying the same innovative therapeutic platform and scientific rigor that made the ...
Researchers from the Centre for Addiction and Mental Health (CAMH) and affiliated organizations presented preclinical data for the α5-GABA-A receptor (α5-GABAAR) positive allosteric modulator GL-II-73 ...
SHANGHAI, Aug. 3, 2025 /PRNewswire/ -- Luye Pharma Group today announced that the first subject has been enrolled in a Phase 1 clinical trial in China for its LY03021, which was filed through China's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback